Distribution of clinical and pathologic variables between high LAM and low LAM cases
Feature . | No. patients with high LAM (%) . | No. patients with low LAM (%) . | Total (%) . | P . |
|---|---|---|---|---|
| No. | 12 (12) | 87 (88) | 99 (100) | — |
| Clinical features | 058* | |||
| IPI Group 1 (0/1) | 4 (33) | 54 (62) | 58 (59) | |
| Group 2 (2/3) | 8 (66) | 32 (37) | 40 (40) | |
| Group 3 (4/5) | 0 (0) | 1 (1) | 1 (1) | |
| BM involvement | 6 (50) | 44 (51) | 50 (51) | |
| Treatment response | NS† | |||
| CR | 6 (50) | 48 (55) | 54 (55) | |
| PR | 6 (50) | 36 (41) | 42 (42) | |
| NR | 0 (0) | 3 (3) | 3 (3) | |
| Pathology features | 046‡ | |||
| FL grade | ||||
| Grade 1 | 6 (50) | 67 (77) | 73 (74) | |
| Grade 2 | 4 (33) | 16 (18) | 20 (20) | |
| Grade 3 | 2 (17) | 4 (5) | 6 (61) | |
| MZ differentiation | 3 (25) | 22 (25) | 25 (25) | NS |
| Transformation | 0 (0) | 8 (9) | 8 (8) | NS |
Feature . | No. patients with high LAM (%) . | No. patients with low LAM (%) . | Total (%) . | P . |
|---|---|---|---|---|
| No. | 12 (12) | 87 (88) | 99 (100) | — |
| Clinical features | 058* | |||
| IPI Group 1 (0/1) | 4 (33) | 54 (62) | 58 (59) | |
| Group 2 (2/3) | 8 (66) | 32 (37) | 40 (40) | |
| Group 3 (4/5) | 0 (0) | 1 (1) | 1 (1) | |
| BM involvement | 6 (50) | 44 (51) | 50 (51) | |
| Treatment response | NS† | |||
| CR | 6 (50) | 48 (55) | 54 (55) | |
| PR | 6 (50) | 36 (41) | 42 (42) | |
| NR | 0 (0) | 3 (3) | 3 (3) | |
| Pathology features | 046‡ | |||
| FL grade | ||||
| Grade 1 | 6 (50) | 67 (77) | 73 (74) | |
| Grade 2 | 4 (33) | 16 (18) | 20 (20) | |
| Grade 3 | 2 (17) | 4 (5) | 6 (61) | |
| MZ differentiation | 3 (25) | 22 (25) | 25 (25) | NS |
| Transformation | 0 (0) | 8 (9) | 8 (8) | NS |